Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1999
12/02/1999WO1999061008A2 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999060869A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
12/02/1999WO1999053958A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
12/02/1999WO1999052519A3 Methods for treating neuropsychiatric disorders
12/02/1999WO1999047173A3 Carrier for in vivo delivery of a therapeutic agent
12/02/1999WO1999040115A3 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
12/02/1999WO1999036064A3 Methods of treating tardive dyskinesia and other movement disorders
12/02/1999WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999DE19823831A1 Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen New pharmaceutical use of isoleucyl thiazolidide and its salts
12/02/1999CA2343317A1 Novel peptides
12/02/1999CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999CA2333667A1 Murd protein and gene of pseudomonas aeruginosa
12/02/1999CA2333320A1 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
12/02/1999CA2333159A1 Method
12/02/1999CA2332999A1 Compounds having ige affecting properties
12/02/1999CA2332989A1 Benzimidazole derivatives as modulators of ige
12/02/1999CA2332985A1 Benzimidazole analogs as down-regulators of ige
12/02/1999CA2332881A1 Minoxidil compositions for external use
12/02/1999CA2332825A1 Peripheral benzodiazepine receptor ligands
12/02/1999CA2332371A1 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract
12/02/1999CA2332369A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329249A1 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2329052A1 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
12/02/1999CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999EP0960618A2 Compositions of clindamycin and benzoyl peroxide for acne treatment
12/01/1999EP0960335A2 Modulators of insulin receptor activity
12/01/1999EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999EP0960211A1 Compositions and methods for the identification and treatment of patients at risk for heart failure
12/01/1999EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES
12/01/1999EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999EP0960118A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959897A1 Method of regulating nitric oxide production
12/01/1999EP0959892A1 Use of pvp or povidone for reducing bowel distension
12/01/1999EP0959891A1 Anthelmintic formulations
12/01/1999EP0959877A1 Correction of genetic defects using chemical chaperones
12/01/1999EP0959876A2 Method for separating active substances in solid pharmaceutical preparations
12/01/1999EP0576612B1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
12/01/1999CN1237104A Fast decomposing pellets
11/1999
11/30/1999USRE36419 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
11/30/1999US5994409 Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
11/30/1999US5994395 Composition for controlling parasites
11/30/1999US5994372 Peripherally active anti-hyperalgesic opiates
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994341 Anti-angiogenic Compositions and methods for the treatment of arthritis
11/30/1999US5994322 Compositions for preventing dementia
11/30/1999US5994319 Synergistic mixture
11/30/1999US5994299 Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them
11/30/1999US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994101 DNA encoding gidA1 polypeptides
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/30/1999US5993845 Histone deacetylase inhibitor and a pharmaceutically acceptable carrier wherein the composition comprises from 0.05 to 100 mg of the histone deacetylase inhibitor.
11/30/1999US5993841 Treating or disorder of the nervous system comprising topically applying an antibiotic; an antihistamine; and a carrier; wherein said antibiotic and said antihistamine are present in relative amounts of 30:70 to 70:30% by weight
11/30/1999US5993833 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition
11/30/1999US5993830 Combining a fatty acid, triethanolamine, propylene glycol, polyvinylpyrrolidone, polydimethylsiloxane, and either glycerol, sorbitol or polyethylene glycol
11/30/1999US5993817 Method to ameliorate osteolysis and metastasis
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993803 Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
11/30/1999CA2180648C Aqueous topical anti-acne compositions of low ph
11/30/1999CA1340833C Activated killer monocytes: tumoricidal activity and method of monitoring same
11/25/1999WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999WO1999060023A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999059636A1 Vegf activity inhibitors
11/25/1999WO1999059635A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
11/25/1999WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999WO1999059628A2 Combination therapy for the treatment of tumors
11/25/1999WO1999059623A1 Methods and means for preventing or treating inflammation or pruritis
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059619A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059612A1 Method for the treatment of gastroesophageal reflux disease
11/25/1999WO1999059611A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/25/1999WO1999059608A2 Osteoporosis treatment
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059601A1 Use of a nucleic acid-binding chemotherapeutic agent, and a pharmaceutical composition
11/25/1999WO1999059600A1 Synergistic composition for use in the treatment of cancer
11/25/1999WO1999059598A1 Use of tricyclic antidepressants for local analgesia
11/25/1999WO1999059597A1 Ionophore containing composition for modulating amyloidosis
11/25/1999WO1999059596A1 Glucocorticoid receptor antagonists for the treatment of dementia
11/25/1999WO1999059594A1 Potassium channel agonists
1 ... 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 ... 1151